These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1777498)

  • 1. Changes in cocaine use after entry to methadone treatment.
    Magura S; Siddiqi Q; Freeman RC; Lipton DS
    J Addict Dis; 1991; 10(4):31-45. PubMed ID: 1777498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of the severity of depressive symptoms among intravenous heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.
    Wang PW; Wu HC; Yen CN; Yeh YC; Chung KS; Chang HC; Yen CF
    Psychol Addict Behav; 2012 Mar; 26(1):145-50. PubMed ID: 21859169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine treatment of cocaine abuse in heroin addicts.
    Pollack MH; Rosenbaum JF
    J Clin Psychiatry; 1991 Jan; 52(1):31-3. PubMed ID: 1988415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of methadone treatment assignment among heroin addicts on first admission to public treatment centres in Italy.
    Bargagli AM; Schifano P; Davoli M; Faggiano F; Perucci CA;
    Drug Alcohol Depend; 2005 Aug; 79(2):191-9. PubMed ID: 16002028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M; McIntosh J; McKeganey N; Robertson M
    Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-infected i.v. drug users in methadone treatment: outcome and psychological correlates--a preliminary report.
    Batki SL; Sorensen JL; Gibson DR; Maude-Griffin P
    NIDA Res Monogr; 1989; 95():405-6. PubMed ID: 2641010
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with client-reported HIV infection among clients entering methadone treatment.
    MacGowan RJ; Fichtner RR; Swanson N; Collier C; Kroliczak A; Cole G
    AIDS Educ Prev; 1997 Jun; 9(3):205-17. PubMed ID: 9241388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambivalence toward methadone treatment among intravenous drug users.
    Rosenblum A; Magura S; Joseph H
    J Psychoactive Drugs; 1991; 23(1):21-7. PubMed ID: 1941364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
    Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns and predictors of cocaine and crack use by clients in standard and enhanced methadone maintenance treatment.
    Grella CE; Anglin MD; Wugalter SE
    Am J Drug Alcohol Abuse; 1997 Feb; 23(1):15-42. PubMed ID: 9048145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone maintenance treatment: a protective factor for cocaine injection in a street-recruited cohort of heroin users.
    Bravo MJ; Llorens N; Barrio G; Brugal MT; Santos S; Sordo L; de la Fuente L;
    Drug Alcohol Depend; 2010 Nov; 112(1-2):62-8. PubMed ID: 20591582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy.
    Avants SK; Margolin A; Usubiaga MH; Doebrick C
    J Subst Abuse Treat; 2004 Mar; 26(2):67-78. PubMed ID: 15050083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug czar seeks new emphasis on methadone treatment.
    AIDS Policy Law; 1997 Oct; 12(20):7. PubMed ID: 11364789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver.
    Kerr T; Marsh D; Li K; Montaner J; Wood E
    Drug Alcohol Depend; 2005 Dec; 80(3):329-35. PubMed ID: 15964714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome.
    Highfield DA; Schwartz RP; Jaffe JH; O'Grady KE
    Addiction; 2007 Nov; 102(11):1816-23. PubMed ID: 17784892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 25-year follow-up of patients admitted to methadone treatment for the first time: mortality and gender differences.
    Jimenez-Treviño L; Saiz PA; García-Portilla MP; Díaz-Mesa EM; Sánchez-Lasheras F; Burón P; Casares MJ; Marina P; Gutiérrez E; Bobes J
    Addict Behav; 2011 Dec; 36(12):1184-90. PubMed ID: 21835551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of drug-dependent patients with methadone. 2: AIDS prevention by drug substitution?].
    Böcker FM
    Fortschr Med; 1991 Feb; 109(5):132-5. PubMed ID: 2045035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus and human immunodeficiency virus-1 co-infection in former heroin addicts in methadone maintenance treatment.
    Piccolo P; Borg L; Lin A; Melia D; Ho A; Kreek MJ
    J Addict Dis; 2002; 21(4):55-66. PubMed ID: 12296502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.